Alleviare India Logo


ARZERRA is a sterile, clear to opalescent, colorless, preservative-free liquid concentrate for intravenous administration. If you have question, please e-mail Allevaire Indian Team or call Allevaire Network on +91-9818274099 (Mr. Kamal Kaushal) for further details.

ARZERRA is supplied at a concentration of 20 mg/mL in single-use vials.

Arzerra contains ofatumumab, which belongs to a group of medicines called monoclonal antibodies.

Arzerra is used to treat chronic lymphocytic leukaemia (CLL). CLL is a cancer of the blood which affects a type of white blood cell called a lymphocytes. The lymphocytes multiply too quickly and live too long, so there are too many of them circulating in your blood.

The disease can also affect other organs in your body. The antibody in Arzerra recognizes a substance on the surface of lymphocytes and binds to them, decreasing the amount of lymphocytes in the body.

ARZERRA (Ofatumumab) Injection suppliers in India. Allevaire India Network New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.


ALLEVIARE LIFE SCIENCES connects the buyer with the supplier who can ship ARZERRA (Cancer Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. ARZERRA is manufactured by GlaxoSmithKline

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for ARZERRA (Ofatumumab) Injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

ARZERRA (ofatumumab) is indicated, in combination with chlorambucil, for the treatment of previously untreated patients with chronic lymphocytic leukemia (CLL) for whom fludarabine-based therapy is considered inappropriate.

ARZERRA is indicated for the treatment of patients with CLL refractory to fludarabine and alemtuzumab.

Please contact +91 9818274099 for ARZERRA 1000mg/50ml (Ofatumumab) price in India.

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Medicine Name: ARZERRA
Generic Name: Ofatumumab
Approval Date: October 27, 2009
Available as (Form & Strength): 100 mg/5 mL single-use vial for intravenous infusion. & 1,000 mg/50 mL single-use vial for intravenous infusion.
Company Name: GlaxoSmithKline

ARZERRA (ofatumumab) is a sterile, clear to opalescent, colorless, preservative-free liquid concentrate (20 mg/mL) for dilution and intravenous administration provided in single-use glass vials with a rubber stopper (not made with natural rubber latex) and an aluminum overseal. Each vial contains either 100 mg ofatumumab in 5 mL of solution or 1,000 mg ofatumumab in 50 mL of solution.

Store ARZERRA refrigerated between 2 ° to 8 ° C (36 ° to 46 ° F). Do not freeze. Vials should be protected from light.


ARZERRA (Ofatumumab) is available.

Get In Touch

    ARZERRA (Ofatumumab) Injection suppliers in India

    ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ARZERRA (Ofatumumab) Injection on prescription and Import License in Patient’s Name only.

    For foreign countries patients, ARZERRA (Ofatumumab) Injection can be made available in Send your inquiry to find ARZERRA (Ofatumumab) Injection in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

    News / Update for ARZERRA (Ofatumumab) Injection

    For ARZERRA (Ofatumumab) Injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details